相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
Brian D. Lehmann et al.
JOURNAL OF PATHOLOGY (2014)
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings
T. M. A. Abdel-Fatah et al.
ANNALS OF ONCOLOGY (2013)
The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer
Z. M. A. Mohammed et al.
BRITISH JOURNAL OF CANCER (2013)
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion
Mamadou Keita et al.
CELL CYCLE (2013)
Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancer
Zahra M. A. Mohammed et al.
HUMAN PATHOLOGY (2013)
Novel prognostic markers for patients with triple-negative breast cancer
Ling Zhou et al.
HUMAN PATHOLOGY (2013)
RUNX family: Regulation and diversification of roles through interacting proteins
Linda Shyue Huey Chuang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
New insights into the role of Runx1 in epithelial stem cell biology and pathology
Cornelia Johanna Franziska Scheitz et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
The RUNX family in breast cancer: relationships with estrogen signaling
N-O Chimge et al.
ONCOGENE (2013)
The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer
Z. M. A. Mohammed et al.
BRITISH JOURNAL OF CANCER (2012)
Runx1: no longer just for leukemia
Ichiro Taniuchi et al.
EMBO JOURNAL (2012)
Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer
Cornelia Johanna Franziska Scheitz et al.
EMBO JOURNAL (2012)
RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis
Kentson Lam et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis
Zahra M. A. Mohammed et al.
HISTOPATHOLOGY (2012)
Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer
Zahra M. A. Mohammed et al.
HISTOPATHOLOGY (2012)
Runx1 Deficiency in CD4+ T Cells Causes Fatal Autoimmune Inflammatory Lung Disease Due to Spontaneous Hyperactivation of Cells
Won Fen Wong et al.
JOURNAL OF IMMUNOLOGY (2012)
Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction
Lea Cunningham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Triple-negative breast cancer: are we making headway at least?
Monica Arnedos et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2012)
RUNX1 and its understudied role in breast cancer
Kevin A. Janes
CELL CYCLE (2011)
Targeted therapies for breast cancer
Michaele J. Higgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
Thomas Karn et al.
PLOS ONE (2011)
Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression
Lixin Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A clinically relevant gene signature in triple negative and basal-like breast cancer
Achim Rody et al.
BREAST CANCER RESEARCH (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Runx1 Directly Promotes Proliferation of Hair Follicle Stem Cells and Epithelial Tumor Formation in Mouse Skin
Charlene S. L. Hoi et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Delineating Genetic Alterations for Tumor Progression in the MCF10A Series of Breast Cancer Cell Lines
Mitsutaka Kadota et al.
PLOS ONE (2010)
Triple-negative breast cancer-current status and future directions
O. Gluz et al.
ANNALS OF ONCOLOGY (2009)
Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency
Hsiang-Yuan Yeh et al.
BMC MEDICAL GENOMICS (2009)
Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant
Clare A. Thibodeaux et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFβ
Michael J. Gorczynski et al.
CHEMISTRY & BIOLOGY (2007)
Observer variation in immunohistochemical analysis of protein expression, time for a change?
T. Kirkegaard et al.
HISTOPATHOLOGY (2006)
Activation of Stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated Src and survivin expression
N Diaz et al.
CLINICAL CANCER RESEARCH (2006)
The RUNX genes: Gain or loss of function in cancer
K Blyth et al.
NATURE REVIEWS CANCER (2005)
分享论文
